Promethazine Dosage for Sedation in Adults
For sedation in hospitalized adult patients, administer 25 to 50 mg of promethazine, with the FDA-approved dose being 25-50 mg for nighttime sedation. 1, 2
Route-Specific Dosing Recommendations
Intramuscular Administration (Preferred Route)
- Deep intramuscular injection is the preferred parenteral route for promethazine due to significant tissue injury risks with other routes 1
- Standard sedation dose: 25-50 mg IM 1
- The deltoid muscle is the recommended injection site for adults 3
Intravenous Administration (Use with Caution)
- If IV administration is necessary, use 25-50 mg infused slowly at ≤25 mg/minute to minimize hypotension risk 4, 1
- Must be diluted to no greater than 25 mg/mL concentration 1
- Preferably inject through functioning IV tubing rather than direct injection 1
- Stop immediately if patient reports pain during injection to evaluate for arterial injection or extravasation 1
Oral Administration
- 25-50 mg orally for nighttime sedation 2
- Onset of action occurs within 20 minutes orally (versus 5 minutes IV) 5
- Oral bioavailability is only 25%, though current dosing recommendations don't adjust for this 5, 6
Critical Timing and Duration Considerations
- Onset of action: 5 minutes IV, 20 minutes PO 5
- Duration of effect: 4-6 hours with effects potentially persisting up to 12 hours 4, 5
- Plasma half-life is 9-16 hours 4, 5
Dose Reduction Strategies
Lower doses (12.5-25 mg) are equally effective for many indications while causing significantly less sedation:
- The American Gastroenterological Association recommends 12.5-25 mg IV as the usual dose, with total doses of 25-100 mg when used as adjuvant to other sedatives 4, 5
- Research demonstrates that 6.25-12.5 mg IV provides equivalent antiemetic efficacy to standard 25 mg doses with reduced sedation 6, 7
- When combining with opioids or benzodiazepines, reduce promethazine dose as sedative effects are synergistic 4, 1, 2
Critical Safety Warnings
Absolute Contraindications
- Never administer intra-arterially due to severe arteriospasm and gangrene risk 1
- Subcutaneous injection is contraindicated due to tissue necrosis risk 1
Serious Adverse Effects to Monitor
- Respiratory depression, particularly when combined with opioids or other CNS depressants 4, 5, 1
- Hypotension, especially with rapid IV administration 4, 1
- Extrapyramidal effects including neuroleptic malignant syndrome, dystonia, and oculogyric crises 4, 5
- Tissue damage including thrombophlebitis, tissue necrosis, and gangrene with improper administration 5, 1
Common Pitfalls to Avoid
- Avoid repeated or prolonged courses due to extrapyramidal effect risks and cumulative respiratory depression 5
- Do not use for chronic sedation - promethazine is inappropriate for long-term use 5
- When used with analgesics or barbiturates, reduce doses of concomitant medications accordingly 1, 2
Practical Algorithm for Sedation Dosing
- First-line approach: Administer 25 mg IM (deep deltoid injection) 3, 1
- If IV access already established: Give 12.5-25 mg IV slowly over at least 1 minute through functioning IV line 4, 1
- If combining with opioids/benzodiazepines: Start with 12.5 mg and reduce doses of other sedatives 4, 5
- May repeat dose within 2 hours if necessary, but transition to oral route as soon as feasible 1
- Maximum consideration: Total doses up to 25-100 mg may be used as adjuvant, but higher doses increase adverse effect risk 4